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Protein synthesis in rabbit reticulocytes: Characteristics of the
protein factor RF that reverses inhibition of protein synthesis
in heme-deficient reticulocyte lysates
(translational regulation/polypeptide chain initiation/protein phosphorylation/eukaryotic initiation factor 2aprotein complexes)

MICHAEL GRACE, ROBERT 0. RALSTON*, AMBICA C. BANERJEE, AND NABA K. GUPTA
Department of Chemistry, The University of Nebraska, Lincoln, Nebraska 68588-0304

Communicated by Myron K. Brakke, August 9, 1982

ABSTRACT During heme deficiency in reticulocyte lysates,
the heme-regulated translational inhibitor of protein synthesis
(HRI) is activated and shuts off protein synthesis. In partial reactions, HRI phosphorylates the Mr 38,000 subunit (a subunit) of
eukaryotic initiation factor 2 (eIF-2), which forms a ternary complex, Met-tRNAf eIF-2 GTP. The eIF-2a(P) thus formed is not
recognized by two eIF-2 ancillary factors, Co-eIF-2B (which promotes the dissociation of the ternary complex at high Mg2+) and
Co-eIF-2C (which reverses the inhibition of ternary complex formation), and thus, is presumably inactive in peptide chain initiation. A protein factor, designated RF, which reverses inhibition
of protein synthesis in heme-deficient reticulocyte lysates, has
been purified -from reticulocyte cell supernatant. RF is a high
molecular weight (Mr 450,000) protein complex composed of
multiple polypeptides. An active RF preparation contains Co-eIF2B and Co-eIF-2C activities, and these two activities in RF preparation are not inhibited by HRI and ATP-i.e., eIF-2a(P) is recognized. During purification, RF remains associated with eIF-2
activity (eIF-2-RF) and can be freed of this eIF-2 activity by CMSephadex chromatography. Both eIF-2 RF and RF contain a Mr
38,000 polypeptide component that is indistinguishable from the
Mr 38,000 subunit of eIF-2 by two-dimensional gel electrophoresis,
It has been observed that a significant part of this Mr 38,000 polypeptide component in eIF-2 RF and almost the entire Mr 38,000
polypeptide component in RF remain unphosphorylated after prolonged incubation with HRI and ATP. A possible role of this free
Mr 38,000 polypeptide in RF action is discussed.

The heme-regulated translational inhibitor of protein synthesis
(HRI) becomes activated during heme deficiency in reticulocyte
lysates. HRI is also a protein kinase and specifically phosphorylates the a-subunit (Mr 38,000) of eukaryotic initiation factor
2 (eIF-2), which forms a ternary complex, Met-tRNAf-eIF-2GTP. However, the precise role of such phosphorylated eIF-2
[eIF-2a(P)] in overall inhibition of protein synthesis is not fully
understood. (For recent reviews, see refs. 1-5.) In partial reactions, HRI inhibits the activities of two eIF-2 ancillary protein
factors, Co-eIF-2B (6-9) and Co-eIF-2C (8-19), as these two
factors do not recognize eIF-2a(P). Co-eIF-2C activity is required for ternary complex formation by eIF-2 in the presence
of Mg2+ (8, 14, 16). Co-eIF-2B promotes the dissociation of the
preformed ternary complex at high Mg 2+ concentrations (5 mM)
and low temperature (00C) (20). The physiological role of CoeIF-2B activity in overall initiation of protein synthesis is not
apparent.
Several laboratories have reported the isolation of a protein
factor, designated RF, from reticulocyte cell supernatant that
reverses inhibition of protein synthesis in heme-deficient re-

ticulocyte lysates (16, 19, 21-24). We previously have reported
that RF also reverses HRI inhibition of ternary complex formation in partial reactions (24). Purified RF preparation contains a Co-eIF-2C-like activity, and this activity in RF preparation can stimulate ternary complex formation by eIF-2a(P)
(24). Partial reversal of HRI inhibition of ternary complex formation by a purified RF preparation also has been reported by
Siekierka et aL (16).
In this communication, we report that a purified RF preparation that actively reverses the inhibition ofprotein synthesis
in heme-deficient reticulocyte lysates contains Co-eIF-2C activity, and this activity in RF preparation is almost completely
resistant to HRI and ATP. Upon further fractionation, this RF
preparation loses considerable activity in inhibition reversal of
protein synthesis, and the Co-eIF-2C activity in fractionated RF
preparation becomes sensitive to HRI. We also report that an
active RF preparation that is almost completely devoid of eIF-2
activity contains the Mr 38,000 subunit (a subunit) of eIF-2, and
this excess Mr 38,000 subunit in RF preparation is not phosphorylated by HRI and ATP. The significance of this observation is not apparent, at present. A possible role of this excess
a subunit in RF action is discussed.
MATERIALS AND METHODS
The sources of the materials used in these studies; preparations
of initiation factors eIF-2, Co-eIF-2B, and Co-eIF-2C; and the
assay methods have been described (8, 24). Protein concentration was determined by the Bradford procedure with bovine
serum albumin as the standard (25).
Purification of RF Activity. We have. adopted a procedure
for the purification of RF based on the method of Amesz et al
(23). In a typical preparation, anemic blood was obtained from
15 rabbits by cardiac puncture. All subsequent operations were
performed at 0-40C. The cells were pelleted by centrifugation
at 5,000 rpm for 5 min in a Sorvall SS-34 rotor, and the buffy
coat was removed by aspiration. The cells were then pooled and
washed twice with 6 volumes of saline solution (130 mM NaCl/
5.2 mM KCI/7.5 mM MgCl2/2 mM Hepes'KOH, pH 7.2) per
volume ofpacked cells by centrifugation at 8,000 rpm for 8 min
in a Sorvall GSA rotor. The packed cells were lysed by addition
of 1.5-2.5 volumes ofice-cold 2 mM Hepes-KOH (pH 7.2). The
lysed cells were swirled on ice for 10 min. The cell debris was
Abbreviations: eIF-2, eukaryotic initiation-factor 2, which forms a ternary complex, Met-tRNAf eIF-2 GTP; Co-eIF-2A, ancillary factor stimulating Met-tRNAf binding to eIF-2; Co-eIF-2B, ancillary factor promoting dissociation of the ternary complex at high Mg2+; Co-eIF-2C,
ancillary factor reversing Mg2+ inhibition ofternary complex formation;
HRI, heme-regulated translational inhibitor; eIF-2a(P), phosphorylated eIF-2 (HRI catalyzed).
* Present address: Department of Microbiology, University of California, San Francisco, CA 94143.
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then pelleted by centrifugation at 12,000 rpm for 20 min in a
Sorvall GSA rotor. Polysomes were removed from the lysate by
centrifugation at 33,000 rpm for 4 hr in a Beckman type 35 rotor.
The resulting supernatant S-100 (350 ml) was adjusted to 0.1
M KCI/20 mM Tris1HCl, pH 7.8/1 mM dithiothreitol/0. 1 mM
sodium EDTA/10% (vol/vol) glycerol (buffer A/0. 1 M KCl) by
addition of a 5-times concentrated stock solution of buffer A/
0.1 M KC1 and stored at -40C overnight. A second preparation
was made the following day to yield a total of 675 ml of S-100
(fraction I). The suspension was then loaded onto a heparinSepharose column (2.6 x 40cm) prepared as described (23) and
was preequilibrated with buffer A/0. 1 M KCL. After the column
was loaded, which generally was done overnight, the column
was washed thoroughly with buffer A/0. 1 M KCL. The adsorbed
proteins were eluted with buffer A/0.5 M KCL. The A2N peak

fractions were pooled and dialyzed against buffer A/0. 1 M KCI
(fraction II).
The dialyzed preparation (fraction II) was made 40% saturated in (NH4)2SO4 by addition of solid (NH4)2SO4, and the
precipitate was pelleted by centrifugation at 10,000 rpm for 10
min in a Sorval SS-34 rotor. The supernatant was then made
80% saturated in (NH4)2SO4, and the precipitate was pelleted
as above. The precipitate was resuspended in buffer A/0.05 M
KCI at =5 A2w/ml and dialyzed overnight against the same
buffer with one change (fraction III). The dialyzed preparation
was loaded onto a DEAE-cellulose (DE-52, Whatman) 1.6
12 cm column preequilibrated with buffer A/0.05 M KCL. The
column was then eluted with buffer A containing a 0.05-0.5 M
KCl gradient (40 ml). One-ml fractions were collected and assayed for RF and Met-tRNAf binding activities. The peak RF
fractions were pooled and dialyzed against 0.1 M KCI/20 mM
potassium phosphate, pH 7.5/1 mM dithiothreitol/O. 1 mM
sodium EDTA/10% glycerol (buffer B/0. 1 M KCI) (fraction IV).
The dialyzed preparation (fraction IV) was loaded onto a
phosphocellulose column (P11, Whatman, 1.0 x 7 cm) and
preequilibrated with buffer B/0. 1 M KCI. The column was
washed thoroughly with the same buffer and then was eluted
with buffer B containing a 0.1-0.7 M KCI gradient (32 ml); 0.8ml fractions were collected. The column fractions were assayed
for RF and eIF-2 activities. The peak fractions containing RF
activity were pooled and concentrated to =1 mg/ml by dialysis
against buffer A/0. 1 M KCI/16% polyethylene glycol (Carbowax 6000, Baker). The RF preparation was then dialyzed extensively against buffer A/0. 1 M KC1. The dialyzed preparation
was further concentrated by passage through a small DEAEcellulose column (column volume, 0.5 ml; equilibrated with
buffer A/0. 1 M KCl) and a one-step elution with buffer A/0.3
M KCI.
Further Fractionation of RF. For further fractionation of RF
into component factor activities, such as eIF-2 and Co-eIF-2C,
the phosphocellulose-purified RF preparation, as described
above, was dialyzed against buffer A/0. 18 M KCI and was applied slowly onto a CM-Sephadex (3.0 cm 1.0 cm) column
previously equilibrated with buffer A/0. 18 M KCl; 0.5-ml fractions were collected. The RF activity was eluted in the column
flow-through and was freed from the bulk of the eIF-2 activity,
which remained bound to the column. The eIF-2 activity could
be eluted by washing the column with buffer A/0.4 M KCL. The
peak fractions were pooled and dialyzed against buffer A/0. 1
M KCI (fraction VI).
For density gradient centrifugation, 0.1 ml of fraction VI was
applied on top of a linear glycerol gradient (14-30%, vol/vol)
in buffer A/0. 1 M KCL. The gradients were centrifuged at
X

X

4S,000

rpm

for 11 hr in

a

Beckman SW-50.1

rotor.

The A.-

profiles of the gradient were monitored, and 0.3-ml fractions
were collected. RF activity sedimented as a single symmetrical

peak around 20 S. The peak fractions were concentrated as before by using a small DEAE-cellulose column equilibrated with
buffer A/0. 1 M KCl and a one-step elution of the RF activity
from the column with buffer A/0.3 M KCI (fraction VII).
Two-Dimensional Gel Electrophoresis. Two-dimensional
gel electrophoresis was performed as described by O'Farrell
(26). Ampholines (pH 3.5-10 and pH 5.7) were purchased from
LKB. The final pH gradient in the isoelectric focusing gels was
linear between pHs 4.5 and 6.6. NaDodSO4/polyacrylamide
gel electrophoresis in the second dimension was on a 15% acrylamide/0.09% N,N'-methylenebisacrylamide gel. Gels were
stained with Coomassie brilliant blue. Autoradiograms were
made with Kodak XR-50 medical x-ray film.

RESULTS
The most active and also the most stable RF preparation was
obtained after the phosphocellulose chromatographic step (fraction V). This preparation also contained significant amounts of
eIF-2, Co-eIF-2A, Co-eIF-2B, and Co-eIF-2C activities. Upon
further fractionation with a CM-Sephadex chromatographic
procedure, the RF preparation (fraction VI) was almost completely freed from eIF-2 activity. However, such RF preparations contained Co-eIF-2A, Co-eIF-2B, and Co-eIF-2C activities. As shown in Fig. 1, both fraction V (phosphocellulose
purified) and fraction VI (CM-Sephadex purified) RF preparations efficiently stimulated protein synthesis in heme-deficient reticulocyte lysates. At higher concentrations, both ofthe
factor preparations increased the initial rate of protein synthesis
over that observed in the presence of hemin, and, in both cases,
protein synthesis continued over a long period. However, we
have observed that the fraction VI RF preparation, which is
devoid of eIF-2 activity, is significantly more unstable than the
fraction V RF preparation and rapidly loses RF activity upon
storage. This loss in RF activity is more pronounced at high
dilution. Conceivably, the presence of eIF-2 confers stability
upon the RF protein complex. Upon further fractionation of
fraction VI RF preparation by using density gradient centrifugation, RF activity was eluted as a single symmetrical peak at
20 S coincident with Co-eIF-2C activity. However, such RF
preparation was very inefficient in stimulating protein synthesis
in heme-deficient reticulocyte lysates, and the protein synthesis
rate declined rapidly after a short period (Fig. 1). The characteristics ofsuch protein-synthesis stimulation observed with this
glycerol density-purified RF preparation were comparable to
those observed with a purified Co-eIF-2C preparation from ribosomal high-salt wash (Fig. 1).
As reported (2), the phosphocellulose-purified RF'preparation (fraction V) contained eIF-2, Co-eIF-2B, and Co-eIF-2C
activities, and the Co-eIF-2B and the Co-eIF-2C activities in
this RF preparation were almost fully resistant to HRI and ATP.
This preparation efficiently formed the ternary complex in the
presence of Mg2+, and such complex formation was completely
insensitive to HRI and ATP at different concentrations of the
fraction tested (Fig. 2). Upon further fractionation, using a CMSephadex chromatographic procedure, the RF preparation
(fraction VI) could be freed of eIF-2 activity. However, this RF
preparation retained the Co-eIF-2C activity, which was partially inhibited by HRI and ATP at low RF concentration and
progressively regained insensitivity to HRI with increasing RF
concentration (Fig. 2B). After glycerol gradient centrifugation,
the RF preparation (fraction VI) regained almost complete sensitivity to HRI and ATP, and HRI inhibition ofternary complex
formation could not be reversed by increasing concentrations
of RF (Fig. 2C). These observations suggest that (i) some additional factor(s) may be present in active RF preparations and
(ii) this factor renders Co-eIF-2C activity insensitive to HRI and
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FIG. 1. Inhibition-reversal activities of RF fractions in protein
synthesis. (A) Fraction V, phosphocellulose-purified RF. (B) Fraction
VI, CM-Sephadex-purified RF. (C) Fraction VII, glycerol gradient RF.
(D) Co-eIF-2C. Protein synthesis in heme-deficient reticulocyte lysates
was assayed by using the standard procedure as described (24) with
increasing amounts of the different RF fractions and Co-eIF-2C. (A)
Phosphocellulose-purified RF at 3 ug (A), 6 ,ug (m), and 9 ,ug (0). (B)
CM-Sephadex-purified RF at 3 Zg (A), 6 ,g (m), and 9 Ag (0). (C) Glycerol gradient RF at 1 jig (A), 2 ,ug (i), 3 ug (a), and 4 ,tg (W). (D) CoeIF-2C at 8 ,ug (A), 16 Ag (m), and 24 ,g (e). ---, Protein synthesis in
the presence or absence of optimal concentrations of hemin (20 ,uM).
[14C]Leucine (specific activity, 112 cpm/pmol) incorporation was determined in 5-,ul aliquots of the incubation mixtures.
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We examined the polypeptide components in fractions V and
VI RF preparations. For this experiment, we incubated the RF
preparations (fractions V and VI) and a partially purified eIF-2
preparation in the presence of HRI and [y-32P]ATP and analyzed the polypeptide components in each fraction by NaDodSO4/polyacrylamide gel electrophoresis and autoradiography (Fig. 3). Both RF preparations (fractions V and VI) showed
multiple polypeptide bands, including several prominent polypeptide bands (Mrs 100,000, 67,000, 53,000, 38,000, and
25,000). As reported (17), several of these polypeptide bands
are also present in a highly purified Co-eIF-2C preparation from
ribosomal salt wash. Both fractions V and VI RF preparations
contained significant amounts of Mr 38,000 polypeptide component(s), which moved similarly to the Mr 38,000 polypeptide
component of eIF-2 (Fig. 3). However, whereas the Mr 38,000
polypeptide component in eIF-2 and in fraction V RF preparation was extensively phosphorylated by HRI and [y-32P]ATP,
the Mr 38,000 polypeptide component in fraction VI RF preparation remained almost completely unphosphorylated. As
noted previously, the fraction V RF preparation contained significant amounts of eIF-2 activity [specific activity (pmol of
Met-tRNAf bound per mg ofprotein), 550], and the fraction VI
RF preparation was almost completely devoid of eIF-2 activity
(specific activity, 15). Both of the RF preparations (fractions V
and VI) at equivalent microgram concentrations had comparable
activities in inhibition reversal of protein synthesis in hemedeficient reticulocyte lysate (see Fig. 1). These results indicate
that the fraction VI RF preparation is enriched with a Mr 38,000
polypeptide component that is not a part of intact eIF-2 and does
not participate in ternary complex formation. Also, this Mr

38
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_

eIF-2

RF
(V)

ATP and is progressively removed by further fractionation with

CM-Sephadex chromatography and glycerol density gradient
centrifugation as the Co-eIF-2C activity in these fractionated
preparations regains sensitivity to HRI and ATP.
elF-2
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FIG. 2. HRI sensitivity of Co-eIF-2C activities in RF fractions. (A)
Fraction V. (B) Fraction VI. (C) Fraction VII. Standard Millipore filtration assay conditions in the presence of 1 mM Mg2+ were used to
measure the binding of [35S]Met-tRNAf to Millipore filters; different
concentrations of the RF fractions were used as indicated. Fractions
VI and VII RF preparations were assayed in the presence of 1 ,ug of
exogenous eIF-2. ---, Without HRI/ATP; , with HRI/ATP.

RF
(V)

RF

(VI)

RF

(VI)

FIG. 3. Phosphorylation of eIF-2 and RF (fractions V and VI). Partially purified eIF-2 and RF preparations (fractions V and VI) were
phosphorylated in the presence of HRI and [y-32PJATP and then analyzed with NaDodSO4/polyacrylamide gel electrophoresis (Left) and
autoradiography (Right). The reaction mixtures contained (total volume, 0.05 ml) 30 mM Tris-HCl (pH 7.8), 130 mM KCl, 7 ltg of bovine
serum albumin, 1.8 mM magnesium acetate, 3 mM dithiothreitol, 1 ,g
of HRI, 0.04 mM [y-32P]ATP (specific activity, 2,500 cpm per pmol),
and, where indicated, 6 ,ug of eIF-2, 6 ,tg of phosphocellulose-purified
RF (fraction V), and 6 ug of CM-Sephadex-purified RF (fraction VI).
The reaction mixtures were incubated at 370 for 10 min. The reactions
were terminated by the addition of an equal volume of a denaturing
buffer containing 50 mM Tris HCl (pH 7.0), 50% glycerol (vol/vol), 5%
2-mercaptoethanol, and .2% NaDodSO4. Samples were run on a gel of
15% acrylamide/0.09% N.N'-methylenebisacrylamide/NaDodSO4.
(A) The stained gels are from a duplicate experiment in which bovine
serum albumin and HRI were omitted. The band patterns were identical with those observed in the duplicate experiments used for autoradiography but did not contain the contaminating bands of bovine
serum albumin and HRI. Mr 38,000 is shown x 103.
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38,000 polypeptide component is not phosphorylated by HRI
and ATP.
To further characterize the Mr 38,000 polypeptide component(s) in fractions V and VI RF preparations, the polypeptide
components in eIF-2 and fractions V and VI RF preparations
were analyzed by two-dimensional gel electrophoresis and autoradiography (Fig. 4 A-I). The Mr 38,000 polypeptide component in eIF-2 moved as a single component with a mobility
corresponding to a pI value of -5 (Fig. 4A). Upon incubation
in the presence of HRI and [y-32P]ATP, a significant part of the
original Mr 38,000 polypeptide in eIF-2 moved towards more
acidic regions (Fig. 4D), and, as expected, this new spot was
radioactively labeled (Fig. 4G) and was presumably phosphorylated. Comparison of the relative intensities of the phosphorylated and nonphosphorylated spots revealed that =80% of the
original Mr 38,000 polypeptide was phosphorylated. Under the
experimental conditions, fractions V and VI RF preparations
contained two Mr 38,000 polypeptide components (Fig. 4 B and
C) of which one had mobility similar to that of the unphosphorylated Mr 38,000 polypeptide of eIF-2. Upon treatment
with HRI and [ y-32P]ATP, a significant part (60%) of the original
Mr 38,000 polypeptide in fraction V RF moved towards more
acidic regions (Fig. 4E) and was phosphorylated (Fig. 4H). Upon
similar treatment, the Mr 38,000 polypeptide in fraction VI remained unchanged (Fig. 4F) and was almost completely unphosphorylated (Fig. 4I).
These results indicate that the fraction VI RF preparation,
which has negligible eIF-2 activity, contains the Mr 38,000 polypeptide (a- subunit) of eIF-2 in the unphosphorylated form,
which is not phosphorylated by HRI and ATP. Both partially
purified eIF-2 and a fraction V RF preparation (which also contains significant amounts of eIF-2 activity) contain a unique and
identical Mr 38,000 polypeptide component in the unphosphorylated form; in both cases, a significant part of this p6lypeptide component becomes phosphorylated in the presence
of HRI and ATP. In the experiment described in Fig. 4D, the
Mr 38,000 polypeptide in eIF-2 was =80% phosphorylated. The
extent of this phosphorylation varied with eIF-2 preparations;
as we have reported previously (8), almost complete phosphorylation of the Mr 38,000 subunit was observed with an extenA

sively purified eIF-2 preparation. The variations in the degree
of phosphorylation of the Mr 38,000 subunit of eIF-2 with different eIF-2 preparations could possibly be due to the presence
of associated RF activity in the eIF-2 preparations (27). It is
conceivable that such RF activity in eIF-2 preparations, as in
fraction VI RF preparation reported in this paper, contains excess free Mr 38,000 subunit that is not phosphorylated by HRI
and ATP. It should be noted that the Mr 38,000 polypeptide in
fraction V RF preparation was significantly less (60%) phosphorylated than was eIF-2. As noted earlier, this RF preparation also contains significant amounts of eIF-2 activity. This
observation is consistent with the postulation that HRI phosphorylates only the Mr 38,000 subunit present in intact eIF-2
molecules and that RF contains excess free Mr 38,000 subunits
that do not participate in ternary complex formation and are not
phosphorylated by HRI and ATP.
DISCUSSION
An RF fraction (fraction V) obtained after phosphocellulose

chromatography during purification actively reversed inhibition of protein synthesis in heme-deficient reticulocyte lysates
and also contained significant amounts of eIF-2, Co-eIF-2B, and
Co-eIF-2C activities. The Co-eIF-2B and Co-eIF-2C activities
in this preparation are resistant to HRI and ATP. Therefore, this
observation provides a rationale for the activity of RF in reversing inhibition of protein synthesis.
However, the precise mechanism of RF action and the altered recognition of Co-eIF-2C in RF preparation is not clear.
A relevant observation reported in this paper is that active RF
preparations contain excess ofthe Mr 38,000 subunit (a subunit)
of eIF-2 in the free form, which is not phosphorylated by HRI
and ATP. The significance of the presence of free a subunit of
eIF-2 in RF preparation is not apparent and may be related to
the basic mechanism of RF action. A likely explanation for RF
action is that RF promotes replacement of the phosphorylated
a subunit in eIF-2 with the nonphosphorylated a subunit in RF
preparation, and the nonphosphorylated eIF-2 thus reformed
is recognized by Co-eIF-2B and Co-eIF-2C and is active in protein synthesis initiation.
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FIG. 4. Two-dimensional gel electrophoresis and autoradiography of partially purified eIF-2 and partially purified RF fractions (fractions V
and VI). Phosphorylation of partially purified eIF-2 (10 tg) and RF [fractions V (12 ,ug) and VI (9 ,ug)] with [y32P]ATP and HRI was as described
in Fig. 3. The reactions were terminated by the addition of an equal volume (50 ul) of denaturing buffer and 28 mg of urea. The reaction mixtures
(100 ,ul) were then loaded on the first-dimension tube gels. The autoradiograms were exposed for 12 hr. The segments of the stained gels (Top and
Middle) and the autoradiograms (Bottom) around the Mr 38,000 (shown x 10-3) polypeptide regions are indicated. (Top) Unphosphorylated eIF-2
(A), RF(V) (B), and RF(VI) (C). (Middle) Phosphorylated eIF-2 (D), RF(V) (E), and RF(VI) (F). (Bottom) Corresponding autoradiograms of Middle
gels (G-I).
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Thus, this paper provides a rationale for RF action and the
relationship of RF to two eIF-2 ancillaryfactor activities-namely,
Co-eIF-2B and Co-eIF-2C. Recently, Siekierka et aL have reported (19) isolation of an RF factor, which they term eIF-2-SP.
This eIF-2'SP preparation presumably contains both eIF-2 and
Co-eIF-2C activities and promotes ternary complex formation
by exogenously added eIF-2 in the presence of Mg2+. According to these authors (19), eIF-2-SP relieves Mg2+ inhibition of
ternary complex formation by eIF-2 as it promotes displacement
of GDP from firmly bound eIF-2-GDP complex. However, the
precise relationship of eIF-2-SP to our Co-eIF-2C and RF factors is not clear. The eIF-2-SP-promoted ternary complex formation by eIF-2 is inhibited by HRI and ATP; therefore, this
factor, as such, does not provide a rationale for RF activity as
it relates to reversal of protein-synthesis inhibition in hemedeficient reticulocyte lysates. We believe that the extensively
purified reticulocyte supernatant factor eIF-2-SP is probably
similar to our glycerol density gradient RF preparation (fraction
VII; see Figs. 1 and 2) which contains HRI sensitive Co-eIF-2C
activity.
Finally, the observation in RF preparations of the presence
of a pool of free a subunit of eIF-2 that is not phosphorylated
by HRI and ATP may provide a rationale for several recent reports, which indicate that only 25-30% ofeIF-2 becomes phosphorylated under conditions ofalmost total inhibition of protein
synthesis in heme-deficient reticulocyte lysates (28, 29). The
presence in reticulocyte lysates of a pool offree a subunit of eIF2 that is not phosphorylated by HRI and ATP could reasonably
explain this lack of correlation between the extent of phosphorylation of a subunits (eIF-2 bound and free) and the degree
of protein-synthesis inhibition in heme-deficient reticulocyte
lysates. Our present results suggest that only eIF-2 bound asubunit is phosphorylated by HRI and ATP.
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work was supported by the United Public Health Service Research
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